What is GHK-Cu? The copper peptide explained
Research context reviewed 5 October 2026GHK-Cu is a three-amino-acid peptide bound to copper. The “Cu” means copper. Its link to skin and connective-tissue research comes from a measurable laboratory finding: cultured fibroblasts made more collagen when exposed to GHK-Cu. See the PEPTALIAS GHK-Cu listing if that is the compound you are comparing.
Is GHK-Cu the same as GHK? Not exactly. GHK names the three-amino-acid peptide; GHK-Cu names its copper-bound complex. “Copper peptide” is a broad label, so check the exact molecule on the listing and study. The collagen experiment used GHK-Cu.
What did the cell studies find?
In a 1988 study, fibroblast cultures produced more collagen. In 1992 research using human fibroblasts in culture, the cells also produced more of certain glycosaminoglycans, components of the framework around cells. These are reasons scientists investigate tissue structure; they are not proof that a vial changes anyone's skin.
Has GHK-Cu been tested on human skin?
Yes, in topical products, not this research vial. In one small randomised comparison after laser resurfacing, 13 people completed the study. The GHK-Cu regimen did not do better on objective redness, wrinkle or overall skin-quality measures, although its users reported higher satisfaction.
GHK-Cu alone or in KLOW?
GHK-Cu alone is the straightforward choice when copper-peptide research is the only question; the listing has 50 mg and 100 mg strengths. KLOW has 50 mg GHK-Cu plus 10 mg each of BPC-157, TB-500 and KPV in a fixed 80 mg blend. The GHK-Cu papers above did not test that blend. See the four KLOW ingredients before choosing one vial over separate compounds.
Need GHK-Cu as a single material? Compare its current vial options.
PEPTALIAS material is for laboratory research only, not human or veterinary use.
Sources: Maquart et al., fibroblast collagen study (1988); Wegrowski et al., human-fibroblast culture study (1992); Miller et al., randomised topical-regimen comparison (2006).